Form 4 for XFOR X4 Pharmaceuticals, Inc
Accepted 2023-10-18 00:00:00 ET · period of report 2023-10-16 · accession 0001628280-23-034579 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-10-18 | 2023-10-16 | XFOR | Woods Keith | Dir | A - Grant | $0.00 | +90.0K | 90.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-10-16 | A | A | 90,000 | $0.00 | 90,000 | D | — | — | (F1) Represents a restricted stock units ("RSUs") grant. The RSUs will vest in three equal annual installments commencing on October 16, 2024, subject to the Reporting Person's continued service as a director through each such date. |